Seminars in Arthritis and Rheumatism

Article	Citations
Corrigendum to “Relapses in giant cell arteritis treated with tocilizumab. Retrospective multicenter study of 407 patients in clinical practice” [Seminars in Arthritis and Rheumatism 71 (2025) 152640]	106
Interstitial lung disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis: chest CT patterns and correlation with survival	82
Risk prediction models for incident systemic lupus erythematosus among women in the Nurses’ health study cohorts using genetics, family history, and lifestyle and environmental factors	80
Combotherapies in immune-mediated inflammatory diseases: A study using the Clinical Data Warehouse from Paris Hospitals’ Public Assistance	73
mRNA vaccines in the rheumatologist's future	73
OMERACT validation of a deep learning algorithm for automated absolute quantification of knee joint effusion versus manual semi-quantitative assessment	71
Hip and pelvis region MRI reference image atlas for scoring inflammation in peripheral joints and entheses according to the OMERACT-MRI WIPE scoring system in patients with spondyloarthritis	64
Hydroxyquinone use does not increase the risk of venous thromboembolism in rheumatoid arthritis patients—Real-world evidence from a population-based cohort study	59
Response letter to the editor	58
OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments	52
Letter to the editor regarding Outcomes in patients with rheumatoid versus osteoarthritis for total hip arthroplasty: A meta-analysis and systematic review	43
Immunotherapy in cancer	42
Update on IgG4-related periaortitis/retroperitoneal fibrosis and periarteritis -recent clinical, diagnostic and therapeutic advances	42
The Autoantibody response in rheumatoid arthritis; what makes it unique?	41
Expanding the role of mycophenolic acid in pediatric lupus nephritis: A holistic approach to extrarenal findings, side effects, and long-term outcomes	38
Response to the correspondence by Xu et al. regarding "Toward a more actionable RA-ILD risk model"	37
Is mixed connective tissue disease (MCTD) a subtype of systemic sclerosis?	36
Factors predictive of severe thrombocytopenia and its impact on poor outcomes in Latin American patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort	36
Risk of malignancy in patients with systemic lupus erythematosus: Systematic review and meta-analysis	35
Hidden in plain sight: Is there a crucial role for enthesitis assessment in the treatment and monitoring of axial spondyloarthritis?	34
Survival of adults with rheumatoid arthritis associated interstitial lung disease - A systematic review and meta-analysis	33
Immunogenicity of Rituximab biosimilar GP2013 in chronic inflammatory rheumatic disorders in daily clinical practice	32
Quantification of coronary artery calcification in systemic sclerosis using visual ordinal and deep learning scoring: Association with systemic sclerosis clinical features	31
Looking at Fibromyalgia differently – the meaning and consequences of fibromyalgia as a dimensional disorder	30
Refining RA-ILD screening: Diagnostic limitations and the emerging role of lung ultrasound	30

Performance of cut-offs of the ASAS Health Index to discriminate between treatment groups in patients with axial spondyloarthritis in the TICOSPA trial	30
Disease characteristics, co-morbidities and treatment response in a contemporary axial spondyloarthritis cohort: Analysis of 717 patients from the Greek AxSpA registry	29
A clue for subclinical CNO in adolescents with acne conglobata and hidradenitis suppurativa: Persistan acute phase rectans elevation	29
Sodium-glucose cotransporter 2 (SGLT2) inhibition and autoimmunity	28
Using patient reported outcomes measurement information system (PROMIS®) measures in rheumatoid arthritis clinical care, research, and trials	28
Prevalence of crystal deposits in asymptomatic hyperuricemia according to different scanning definitions: A comparative study	27
Are there causal mucosal drivers in the preclinical development of rheumatoid arthritis?	27
AA amyloidosis in inflammatory joint diseases: A systematic review	25
Corrigendum to “The Glucocorticoid Toxicity Index: Measuring Change in Glucocorticoid Toxicity Over Time” [Seminars in Arthritis and Rheumatism 55 (2022):152010]	25
Real-world assessment of the efficacy and tolerability profile of JAK inhibitors in difficult-to-treat rheumatoid arthritis	25
A cohort study on the associations between age at natural menopause and rheumatoid arthritis in postmenopausal women from the Canadian Longitudinal Study on Aging	25
Response to: Comment to “Vitamin D in psoriatic arthritis—A systematic review and meta-analysis”	25
A randomized controlled trial evaluating the effects of social networking on chronic disease management in rheumatoid arthritis	24
Assessing domain match and feasibility of candidate instruments matching with OMERACT endorsed domains to measure flare in knee and hip osteoarthritis	24
Interstitial lung disease phenotype in mixed, differentiated, or overlapping, connective tissue diseases: Comment on the article by Boleto et al.	23
Raynaud's phenomenon secondary to central nervous system stimulants: A therapeutic role of α-1 adrenergic blockers?	23
Response letter to the Editor	23
Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: The pragmatic, multicenter, placebo-controlled GLORIA trial	23
A population-based analysis of rheumatology care patterns for inflammatory arthritis during COVID-19 in Alberta, Canada	23
The ASAS-OMERACT core domain set for axial spondyloarthritis	22
The clinical features of juvenile dermatomyositis: A single-centre inception cohort	22
Psychological stress in rheumatoid arthritis: a systematic scoping review	22
Imaging to predict early relapses after treatment discontinuation in patients with large vessel giant cell arteritis – A cohort study	22
Longitudinal changes on cranial magnetic resonance imaging in relapsing giant cell arteritis	22
Hematopoietic stem cell transplant, chimeric antigen receptor T-cells, and other cellular therapies as stepping stones toward long-term improvement in severe scleroderma and other autoimmune diseases	21
Methotrexate treatment in hand osteoarthritis refractory to usual treatments: A randomised, double-blind, placebo-controlled trial	21
Targeting the Wnt pathway for the treatment of Osteoarthritis of the knee	21
Molecular mechanisms underlying thrombosis in systemic lupus erythematosus – A Systematic review	21
Giant cell arteritis associated with scalp, tongue or lip necrosis: A French multicenter case control study	21
Is there a role for Pneumocystis jiroveci pneumonia prophylaxis in giant cell arteritis or polymyalgia rheumatica?	20
Improvement of bone mineral density and new vertebral fractures during 8 years of TNF-α inhibition in patients with axial spondyloarthritis	20
Women with Rheumatoid Arthritis have similar rates of postpartum maternal outcomes compared to women without autoimmune disease	20
Therapeutic approach to central nervous system involvement of Behçet's disease	20
HRCT imaging of pulmonary involvement in granulomatosis with polyangiitis and microscopic polyangiitis at disease onset and during follow-up	20
Response to commentary on IgG4-related uveitis. A French cohort and literature review	20
Effect of zoledronic acid with or without methylprednisolone on 3D bone area and bone shape in patients with symptomatic knee osteoarthritis: A post-hoc analysis of the ZAP2 trial	19
Response: Early referral of patients with suspected polymyalgia rheumatica: An active involvement of the out-of-hospital public rheumatologist is needed. Reply letter to Ciro Manzo (letter to the edit	19
Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofaciti	19
Systematic review of colchicine neuromyopathy: Risk factors, duration and resolution	19
The autoimmune rheumatological presentation of Common Variable Immunodeficiency Disorders with an overview of genetic testing	19
Multiple morbidities are associated with serious infections in patients with rheumatoid arthritis	19
Mechanisms of joint pain: Five short lessons from osteoarthritis	18
Effects of exercise-based interventions on inflammatory markers in patients with fibromyalgia: A systematic review and meta-analysis	18
Discriminating capacity of the ASAS health index in patients with axial spondyloarthritis treated with ixekizumab	18
The control group matters: Pain, physical function and strength improvements relative to the comparator intervention in knee and hip osteoarthritis	18
CAR T-cell therapy in SLE: A systematic review	18
Real-world persistence of urate-lowering therapy following a treat-to-target intervention: A two-year follow-up analysis of the STOP gout trial	18
Defining a personalized treatment approach to rheumatoid arthritis: Using genetic markers of TNFi response	18
The Role of Myositis-Specific Autoantibodies and the Management of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies: A Systematic Review	18
Risk factors for invasive fungal infections in patients with connective tissue disease: Systematic review and meta-analysis	18

Factors associated with atherosclerosis in radiographic and non-radiographic axial spondyloarthritis. A multicenter study on 838 patients	18
Looking at fibromyalgia differently – An observational study of the meaning and consequences of fibromyalgia as a dimensional disorder	17
The role of sex and systemic inflammation in the development of cardiovascular disease in osteoarthritis: A population-based cohort study using the CLSA	17
Causal association of diet-derived circulating antioxidants with the risk of rheumatoid arthritis: A Mendelian randomization study	17
Standardizing health outcomes for people with rheumatoid arthritis receiving disease modifying drug therapy: A rapid review of patient-decision aids and preference studies to inform the development of	17
Sarcoidosis incidence after mTOR inhibitor treatment	17
Further expanding the clinical spectrum of giant cell arteritis: Non-classical organ involvement and uncommon complications	17
Pathogenesis and targets in uveitis	16
Advances in Targeted Therapies (ATT) What's cooking in the academic's kitchen? 3TR (IMI)	16
Phenotype of diffuse cutaneous systemic sclerosis patients with positive anticentromere antibodies: A systematic literature review and meta-analysis	16
Association between Kawasaki disease and subsequent autoimmune disease: National cohort study of adolescents with 12-year follow-up from birth	16
Male rheumatoid arthritis patients at substantially higher risk for cardiovascular mortality in comparison to women	16
Juvenile and adult-onset scleroderma: Different clinical phenotypes	16
Prognostic factors in giant cell arteritis associated aortitis with PET/CT and CT angiography at diagnosis	16
Synovial fibroblasts in juvenile idiopathic arthritis: A scoping review	16
Modelling long-term outcomes for patients with systemic lupus erythematosus	15
Central sensitization has major impact on quality of life in patients with axial spondyloarthritis	15
Factors associated with cardiovascular events in systemic lupus erythematosus in a monocentric cohort with up to 40 years of follow-up	15
Effects of neuromuscular control and strengthening exercises on MRI-measured thigh tissue composition and muscle properties in people with knee osteoarthritis – an exploratory secondary analysis from	15
Comments on the article by Goldman et al.	15
Biologics in peripheral ulcerative keratitis	15
Table of Contents	14
COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis	14
Comparison between rheumatoid arthritis with malignant lymphoma and other malignancies: Analysis of a National Database of Rheumatic Disease in Japan	14
The shrinking toe sign in gout	14
Reply on: International, multidisciplinary Delphi consensus recommendations on non-pharmacological interventions for fibromyalgia	14
Efficacy, safety, and cost-effectiveness of therapeutic drug monitoring (TDM) for TNF inhibitor therapy in rheumatic disease: A systematic review and meta-analysis	14
Autoinflammatory syndromes with coexisting variants in Mediterranean FeVer and other genes: Utility of multiple gene screening and the possible impact of gene dosage	14
Co-occurrence of giant cell arteritis in patients with polymyalgia rheumatica. Comment on the article by Nielsen AW, et al	14
Is glucocorticoid bridging therapy associated with later use of glucocorticoids and biological DMARDs during the disease course of patients with rheumatoid arthritis in daily practice? A real-world da	14
Minimally invasive interventional procedures for osteoarthritis and inflammatory arthritis: A systematic review and meta-analysis	13
Predicting best treatment in rheumatoid arthritis	13
Predicting anxiety and depression in systemic lupus erythematosus: the role of inflammation, sociodemographic variables and clinical factors	13
Defining domains: developing consensus-based definitions for foundational domains in OMERACT core outcome sets	13
Psychometric properties of patient-reported outcomes measurement information system (PROMIS) fixed short forms in Juvenile Myositis	13
Response to the letter entitled " Letter to the editor to Soluble CXCL16 is a prognostic biomarker associated with rapidly progressive interstitial lung disease complicated with dermatomyositis" by Ga	13
Unraveling the role of neutrophil extracellular traps in rheumatoid arthritis: From triggers to therapeutic targets	13
Comparative analysis of disease outcomes: Early vs. late transition from psoriasis to psoriatic arthritis	13
Does the time to the onset of lupus nephritis impact renal disease presentation and outcomes?	13
Response to: ‘Critical Commentary ‘Infectious complications of Belimumab with standard care in systemic lupus erythematosus: A systematic review and meta-analysis’ by Saketh Sainag Mandiga et al	13
Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: A systematic review	13
Diagnostic value of different imaging features for patients with suspected gout: A network meta-analysis	13
An analysis of the first relapse in giant cell arteritis using ultrasonography	13
Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus	13
Remission in gout is possible: 5-year follow-up in the NOR-Gout study	13
Rheumatoid arthritis and the risk of 90-day readmission after hospitalization for heart failure	13
Relapses in giant cell arteritis treated with tocilizumab. Retrospective multicenter study of 407 patients in clinical practice	13
Methotrexate use reduces mortality risk in rheumatoid arthritis: A systematic review and meta-analysis of cohort studies	13
Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group	13
Preventive effect of beta-blockers in the development of aortic dilation in giant cell arteritis-related aortitis	13
Subclinical coronary artery calcification in systemic sclerosis using high-resolution chest CT: Identification, extent, and disease-specific risk factors	13
Incidence and prevalence of systemic sclerosis in Sweden, 2004–2015, a register-based study	12
Acknowledgement of Referees	12
Efficacy and safety of anti-Tumor Necrosis Factor-α biosimilars in Juvenile Idiopathic Arthritis - a systematic review and meta-analysis	12
Self-esteem, self-concept, and body image of young people with rheumatic and musculoskeletal diseases: A systematic literature review	12
Risk of incident gout following exposure to recombinant zoster vaccine in US adults aged ≥65 years	12
Aortic disease in giant cell arteritis	12
Cognitive impairment and other neuropsychiatric manifestations in patients with primary vasculitis: a systematic review	12
The natural history of end-stage knee osteoarthritis: Data from the osteoarthritis initiative	12
Developing efficient predictive models for the diagnosis of VEXAS syndrome	12
Defining patient perception of overall well-being and disease activity in the OMERACT Juvenile Idiopathic Arthritis (JIA) core domain set: A report from the JIA working group	12
Patient perspective on remission in rheumatoid arthritis: Validation of patient reported outcome instruments to measure absence of disease activity	12
Definitions of rheumatoid arthritis flare and how they relate to patients’ perspectives: A scoping review of qualitative and quantitative evidence	12
Giant cell arteritis-related stroke in a large inception cohort: A comparative study	12
Risk of new onset of immune-mediated diseases after SARS-CoV-2 infection: A systematic review and meta-analysis	12
Historical bioarcheological aspects of diffuse idiopathic skeletal hyperostosis in humans	12
Algorithmic approaches in hand imaging for rheumatic musculoskeletal diseases: A systematic literature review	12
How is early spondyloarthritis defined in the literature? Results from a systematic review	12
The prognostic power of anti-topoisomerase I and anti-centromere antibodies in systemic sclerosis - A systematic review of the literature	12
Immunosuppressive therapy to treat newly diagnosed primary heart involvement in patients with systemic sclerosis: An Italian cardiac magnetic resonance based study	12
Autoimmune rheumatic disease in Australian Aboriginal and Torres Strait Islander Peoples: What do we know?	12
Prevalence of frailty and prefrailty in systemic lupus erythematosus: A systematic review and meta-analysis	11
Longitudinal relationships between cognitive domains and depression and anxiety symptoms in systemic lupus erythematosus	11
Impact of previous glucocorticoid therapy on diagnostic accuracy of [18F] FDG PET-CT in giant cell arteritis	11
Assessment of triple antiphospholipid antibody-positive patients based on clinical and laboratory domains of 2023 ACR/EULAR antiphospholipid syndrome classification criteria	11
Efficacy and safety of pharmacological treatments for autoimmune disease-associated interstitial lung disease: A systematic review and network meta-analysis	11
COVID-19 vaccinations and infections among individuals with systemic sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study	11
Giant cell arteritis – New treatment targets at the horizon	11
Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain set	11
Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: Clinical features, biomarkers, and treatment options	11

Does body mass index mediate the relationship between socioeconomic position and incident osteoarthritis?	11
A prospective observational cohort study and systematic review of 40 patients with mouth and genital ulcers with inflamed cartilage (MAGIC) syndrome	11
Neuropathic pain in spondyloarthritis: Decoding its prevalence, risk factors, and impact on disease activity	11
Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials	11
Age of onset of rheumatoid arthritis and radiographic changes	11
Outcomes in ANCA-associated vasculitis patients with end-stage kidney disease on renal replacement therapy—A meta-analysis	11
Severity and mortality of COVID-19 in patients with systemic sclerosis: a Brazilian multicenter study	11
Telemedicine in rheumatology care: A systematic review	11
Diffuse generalized venulitis as the primary pathology of Behçet's disease: A comprehensive magnetic resonance venography study	11
SARS-CoV-2-specific T-cell responses after COVID-19 recovery in patients with rheumatic diseases on immunosuppressive therapy	11
[18F]Sodium Fluoride PET has the potential to identify active formation of calcinosis cutis in limited cutaneous systemic sclerosis	10
Patients’ perspectives on systemic sclerosis-related Raynaud's phenomenon in the feet: A qualitative study from the OMERACT Foot and Ankle Working Group	10
Comparing Raynaud’s phenomenon attack measurement tools: paper or smartphone application?	10
Patient perspectives on long-term outcomes in rheumatoid arthritis. A qualitative study from the OMERACT patient outcomes in longitudinal studies working group	10
Racial differences in persistent glucocorticoid use patterns among medicaid beneficiaries with incident systemic lupus erythematosus	10
Clinical association of health-related quality of life and mortality in an antineutrophil cytoplasmic antibody-associated vasculitis cohort	10
The immune pathology of bursitis in rheumatic inflammatory diseases, degenerative conditions and mechanical stress: A systematic review	10
Effects of cumulative lifetime estrogen exposure on the clinical characteristics and courses in postmenopausal women with rheumatoid arthritis	10
Diffuse idiopathic skeletal hyperostosis (DISH) and trabecular bone score (TBS) in postmenopausal women: The Camargo cohort	10
Correspondence on “Allopurinol adherence, persistence and patterns of use in individuals with diabetes and gout: A retrospective, population-based cohort analysis” by Weisman et al.	10
SAPHO syndrome: Patient stratification and the new horizon of precision medicine	10
Sodium-glucose cotransporter 1 inhibition and gout: Mendelian randomisation study	10
Variations in Takayasu arteritis characteristics in a cohort of patients with different racial backgrounds	10
Impact of biologics on health-related quality of life in patients with Ankylosing spondylitis: A systematic review and meta-analysis of randomized controlled trials	10
Reply to: Expanding the role of mycophenolic acid in pediatric lupus nephritis: A holistic approach to extrarenal findings, side effects, and long-term outcomes	10
Immune checkpoint inhibitors and rheumatoid arthritis: All roads lead to PD-1?	9
Corrigendum to ‘TNF-alpha inhibition for the treatment of cardiac sarcoidosis’ seminars in arthritis and rheumatism. 2020 Jun;50(3):546-552	9
Sleep disorders in rheumatoid arthritis: Incidence, risk factors and association with dementia	9
Validation studies of rheumatoid arthritis patient-reported outcome measures in populations at risk for inequity: A systematic review and analysis using the OMERACT summary of measurement properties e	9
Systematic review of imaging tests to predict the development of rheumatoid arthritis in people with unclassified arthritis	9
Bone and entheseal targets for growth factors in diffuse idiopathic skeletal hyperostosis	9
Role of intravenous immunoglobulins in systemic sclerosis (SSc): A systematic literature review	9
Differences in the autoantibody phenotypes and long-term outcomes between juvenile- and adult-idiopathic inflammatory myopathies	9
Effectiveness and safety of anti-CD20 monoclonal antibodies versus csDMARDs in anti-Jo-1 antisynthetase syndrome: A retrospective cohort study	9
Polygenic risk scores	9
Trends in adverse pregnancy outcomes among women with systemic sclerosis in the United States	9
Corrigendum to The Glucocorticoid Toxicity Index: Measuring Change in Glucocorticoid Toxicity Over Time [Seminars in Arthritis and Rheumatism Volume 55, 152010]	9
Disease activity at conception predicts lupus flare up to two years after birth: A multicentre long term follow-up study	9
Does smoking protect against developing osteoarthritis? Evidence from a genetically informed perspective	9
Evolution of bone lesions in adults with chronic nonbacterial osteitis (CNO): A long-term follow-up study	9
Taper versus discontinuation of tocilizumab in patients with giant cell arteritis: Real-world experience from a tertiary center	9
Macrophages–Autoimmunity–Treatment option	9
Joint and muscle inflammatory disease: A scoping review of the published evidence	9
Strategies to promote implementation of core outcomes for medication adherence trials in rheumatology: A report from the OMERACT-Adherence Group	9
Adipocytokines and achievement of low disease activity in rheumatoid arthritis	9
Reply on: a meta-analysis of clinical manifestations in asian systemic lupus erythematous: The effects of ancestry, ethnicity and gender	8
Healthy dietary pattern and risk of rheumatoid arthritis: A systematic review and meta-analysis	8
Risk of major adverse cardiovascular events following targeted therapy in patients with rheumatoid arthritis: a real-world analysis stratified by cardiovascular risk	8
Consensus-driven conceptual development of a standardized whole body-MRI scoring system for assessment of disease activity in juvenile idiopathic arthritis: MRI in JIA OMERACT working group	8
Factors associated with thrombosis in Behçet Syndrome: A systematic review and meta-analysis	8
Navigating the path of progress: The OMERACT 2023 emerging leaders program	8
Baseline serum biomarkers of inflammation, bone turnover and adipokines predict spinal radiographic progression in ankylosing spondylitis patients on TNF inhibitor therapy	8
Ultra-high frequency ultrasound for digital arteries: improving the characterization of vasculopathy in systemic sclerosis	8
Early-onset juvenile dermatomyositis: A tertiary referral center experience and review of the literature	8
Increasing uptake through collaboration in the development of core outcome sets: Lessons learned at OMERACT 2023	8
Referees	8
Comprehensive analysis of disease activity, neuropsychiatric symptoms, imaging features and risk factors for seizure in hospitalized patients with juvenile-onset neuropsychiatric systemic lupus erythe	8
Serum ferritin as a significant biomarker for patients with idiopathic inflammatory myopathy-associated interstitial lung disease: A systematic review and meta-analysis	8
Why most (but perhaps not all) DMARDs work equally well	8
Management of disease progression after autologous hematopoietic stem cell transplantation in systemic sclerosis: Results from an international questionnaire-based study	8
Traditional laboratory parameters and IFNγ-related biomarkers in the diagnosis and management of MAS	8
Come rain or shine: Is weather a risk factor for musculoskeletal pain? A systematic review with meta-analysis of case-crossover studies	8
Effect modification by contextual factors of urate-lowering therapy on serum urate in people with gout: A systematic review with meta-regression analysis	8
Development of a prediction model for poor prognosis in childhood-onset Takayasu's arteritis	8
Menopausal hormone therapy and risk of seropositive rheumatoid arthritis: A nationwide cohort study in Korea	8